For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250902:nRSB6451Xa&default-theme=true
RNS Number : 6451X JSC National Atomic Co. Kazatomprom 02 September 2025
AIX: KAP, KAP.Y (GDR)
LSE: KAP (GDR)
2 September 2025, Astana, Kazakhstan
Notice of the Extraordinary General Meeting of Shareholders
National Atomic Company "Kazatomprom" JSC ("the Company" or "Kazatomprom"),
address: 17/12 Syganak Street, Nura District, Astana, Z05T1X3, Republic of
Kazakhstan, hereby notifies the Company shareholders of its absentee
Extraordinary General Meeting of Shareholders ("the Meeting"), convened at the
initiative of the Board of Directors of Kazatomprom (Minutes No. 7/25 dated 26
August 2025), in accordance with Articles 35-41, 43-47, 49-52 of the Law of
the Republic of Kazakhstan "On Joint Stock Companies".
Date and time when the list of shareholders entitled to participate in the
Meeting will be compiled: 19 September 2025 at 00:00 local time (GMT+5).
Start date for submitting absentee voting ballots: 10 October 2025.
Closing date for submitting absentee voting ballots: 17 October 2025, 18:00
local time (GMT+5).
Date of absentee vote counting: 20 October 2025 until 18:00 local time
(GMT+5).
Agenda of the Extraordinary General Meeting of Shareholders
1. On concluding the Letter Agreement No. 3 to the Long-term contract between
Kazatomprom and CNNC Overseas Limited No. CNOL2023-50 dated 26 June 2023 for
the sale and purchase of natural uranium concentrates.
2. On amending the decision of the Extraordinary General Meeting of
Shareholders of Kazatomprom dated 15 November 2024 (Minutes No. 3) on the
fourth agenda item "Concluding a major transaction as a result of which
Kazatomprom acquires or alienates (may acquire or alienate) property, the
value of which is more than fifty percent of the total book value of
Kazatomprom assets as of the date of approving the transaction as a result of
which more than fifty percent of the total book value of its assets is
acquired or alienated (may be acquired or alienated), namely: the spot
contract for the sale and purchase of natural uranium concentrates between
Kazatomprom as the "Seller" and CNNC Overseas Limited as the "Buyer" and the
long-term agreement for the sale and purchase of natural uranium concentrates
between Kazatomprom as the "Seller" and China National Uranium Corporation
Limited as the "Buyer".
Basis for bringing these items to the General Meeting of Shareholders' voting
Following the decision of the Annual General Meeting of Shareholders of
Kazatomprom dated 25 May 2023, the Company and CNNC Overseas Limited ("CNOL")
concluded the Long-term contract for the sale and purchase of natural uranium
concentrates No. CNOL2023-50 dated 26 June 2023.
On 15 November 2024 the Extraordinary General Meeting of Shareholders of
Kazatomprom approved the conclusion of the Spot contract for the sale and
purchase of natural uranium concentrates with CNOL and the Long-term agreement
for the sale and purchase of natural uranium concentrates with China National
Uranium Corporation ("CNUC"). In accordance with this decision, the Company
and CNOL concluded the Spot contract for the sale and purchase of natural
uranium concentrates No. CNOL-2024-156 dated 15 November 2024, under which
the delivery of natural uranium concentrates was completed in full.
At the same time, the conclusion of the Long-term agreement for the sale and
purchase of natural uranium concentrates with CNUC was postponed due to
additional editorial comments to the agreement which were received from the
authorized bodies of CNUC. In order to reflect certain clarifications and
edits in the existing Long-term contract with CNOL No. CNOL2023-50 dated 26
June 2023 for the sale and purchase of natural uranium concentrates and in the
draft of the Long-term agreement for the sale and purchase of natural uranium
concentrates with CNUC, the parties agreed on the draft Letter Agreement No. 3
to the Long-term contract No. CNOL2023-50 dated 26 June 2023 for the sale and
purchase of natural uranium concentrates and the new draft Long-term agreement
for the sale and purchase of natural uranium concentrates with CNUC. At the
same time, the material terms of these transactions (volumes, prices, delivery
schedules) remain unchanged and confidential. Because the approval of both
transactions lied within the competence of the General Meeting of Shareholders
of the Company (as per legislation and the Company's Charter), any changes
related to such transactions, including non-material edits and amendments to
the corresponding agreements, shall also be brought to the Company's General
Meeting of Shareholders and need to be voted upon.
CNUC, a company registered in the People's Republic of China, and CNOL, a
company registered in Hong Kong, both are affiliated entities of China
National Nuclear Corporation (CNNC) - a state corporation of the People's
Republic of China involved in all areas of nuclear industry. CNNC is the main
operator of nuclear power plants in China and is engaged in R&D in nuclear
energy and technologies, construction of nuclear power plants and production
of nuclear fuel.
Materials for the Meeting according to the agenda will be available to
shareholders no later than 10 days before the date of the Meeting, at the
Company's headquarters in accordance with clause 4 of Article 44 of the Law
"On Joint Stock Companies". Upon request, physical copies of the Meeting
materials will be sent within 3 business days of receipt of the request, with
the costs related to compilation and delivery of the documents being borne by
the shareholder. Requests from the shareholders of the Company must be
received at the actual address of the Company, in the way prescribed by the
legislation of the Republic of Kazakhstan.
The notice of the upcoming Meeting as well as the ballot for absentee voting
will also be available on the Company's website in accordance with the Law "On
Joint Stock Companies" and the Company's Charter.
The Company hereby invites shareholders of Kazatomprom to review the following
Meeting procedures:
· When voting by an absentee ballot, a shareholder shall indicate
his/her full name/name of a legal entity, the number of voting shares, and
shall choose one of the voting options.
· An absentee ballot shall be signed by a shareholder - an
individual (a representative of a shareholder - an individual), who shall
indicate his/her identity document (ID / passport number, date of issue,
issuing authority, and individual identification number (IIN)). A shareholder
shall also provide a copy of his/her identity document.
· Absentee voting ballot of a shareholder - a legal entity shall be
signed by its CEO (a representative of a shareholder - a legal entity).
· A ballot which is not signed by a shareholder - an individual, or
the CEO of a shareholder - a legal entity or a representative of a
shareholder - an individual, or a representative of a shareholder - a legal
entity, shall be deemed invalid.
· Only one voting option shall be marked in the ballot.
· The absentee ballot shall be received by the Company or delivered by
courier to the office of Kazatomprom at the address: 17/12 Syganak Street,
Nura District, Astana, Z05T1X3, Republic of Kazakhstan, no later than 18:00
local time (GMT+5) on 17 October 2025.
· In case of signing a ballot for absentee voting by the representative
of the shareholder, the ballot for absentee voting is followed by the copy of
power of attorney or other document confirming the powers of the shareholder's
representative.
· For vote counting, only those votes on the agenda items are counted
where a shareholder (or a representative of a shareholder) followed the
procedure of voting prescribed in the ballot, and only one of the voting
options was marked.
· The Meeting may consider and make decisions on the agenda items only if
the shareholders (or representatives of shareholders), included in the list of
shareholders entitled to participate and vote, and owning in total fifty or
more percent of voting shares of the Company, were registered as of the
date or on the closing date for submission of ballots.
· The list of the Company's shareholders entitled to participate and
vote at the Meeting is compiled by the Central Securities Depository JSC based
on the data of Kazatomprom's shareholders register system.
· If, after compiling a list of shareholders entitled to
participate and vote at the Meeting, a person included in such a list
alienated his/her voting shares, the right to participate in the Meeting is
transferred to a new shareholder. In such a case, the documents confirming the
ownership of the shares shall be submitted.
· Any shareholder of Kazatomprom has the right to participate in the
management of the Company in the manner prescribed by Law of the Republic of
Kazakhstan "On Joint-Stock Companies" and the Charter of the Company.
· The holders of Global Depositary Receipts are entitled to vote at
the Meeting on behalf of the beneficial owners in relation to the deposited
shares, provided that identification and other information required by the
applicable Kazakhstan law on such beneficial owners, has been submitted to the
Central Securities Depository JSC through the Depositary (Citibank N.A.).
For more information, please contact:
Extraordinary General Meeting of Shareholders Inquiries
Aigerim Dosanova, Corporate Secretary
Tel.: +7 7172 45 82 84
Email: adosanova@kazatomprom.kz (mailto:adosanova@kazatomprom.kz)
Investor Relations Inquiries
Botagoz Muldagaliyeva, Director, Investor Relations
Tel.: +7 7172 45 81 80/69
Email: ir@kazatomprom.kz (mailto:ir@kazatomprom.kz)
Public Relations and Media Inquiries
Daniyar Oralov, Director, Public Relations
Tel: +7 7172 45 80 63
Email: pr@kazatomprom.kz (mailto:pr@kazatomprom.kz)
A copy of this announcement is available at www.kazatomprom.kz
(http://www.kazatomprom.kz) .
About Kazatomprom
Kazatomprom is the world's largest producer of uranium with the Company's
attributable production representing approximately 21% of global primary
uranium production in 2024. The Group benefits from the largest reserve base
in the industry and operates, through its subsidiaries, JVs and Associates, 27
deposits grouped into 14 mining assets. All of the Company's mining operations
are located in Kazakhstan and extract uranium using ISR technology with a
focus on maintaining industry-leading health, safety and environment standards
(ISO 45001 and ISO 14001 certified).
Kazatomprom securities are listed on the London Stock Exchange and the Astana
International Exchange. Kazatomprom is the national atomic company in the
Republic of Kazakhstan, and the Group's primary customers are operators of
nuclear generation capacity, the main export markets for the Group's products
are Asia, Europe and North America. The Group sells uranium and uranium
products under long-term contracts, short-term contracts as well as in the
spot market, directly from its headquarters in Astana, Kazakhstan, and through
its Switzerland-based trading subsidiary, Trade House KazakAtom AG (THK).
For more information, please see the Company website at www.kazatomprom.kz
(http://www.kazatomprom.kz) .
Forward-looking statements
All statements other than statements of historical fact included in this
communication or document are forward-looking statements. Forward-looking
statements give the Company's current expectations and projections relating to
its financial condition, results of operations, plans, objectives, future
performance and business. These statements may include, without limitation,
any statements preceded by, followed by or including words such as "target,"
"believe," "expect," "aim," "intend," "may," "anticipate," "estimate," "plan,"
"project," "will," "can have," "likely," "should," "would," "could" and other
words and terms of similar meaning or the negative thereof. Such
forward-looking statements involve known and unknown risks, uncertainties and
other important factors beyond the Company's control that could cause the
Company's actual results, performance or achievements to be materially
different from the expected results, performance or achievements expressed or
implied by such forward-looking statements. Such forward-looking statements
are based on numerous assumptions regarding the Company's present and future
business strategies and the environment in which it will operate in the
future.
THE INFORMATION WITH RESPECT TO ANY PROJECTIONS PRESENTED HEREIN IS BASED ON A
NUMBER OF ASSUMPTIONS ABOUT FUTURE EVENTS AND IS SUBJECT TO SIGNIFICANT
ECONOMIC AND COMPETITIVE UNCERTAINTY AND OTHER CONTINGENCIES, NONE OF WHICH
CAN BE PREDICTED WITH ANY CERTAINTY AND SOME OF WHICH ARE BEYOND THE CONTROL
OF THE COMPANY. THERE CAN BE NO ASSURANCES THAT THE PROJECTIONS WILL BE
REALISED, AND ACTUAL RESULTS MAY BE HIGHER OR LOWER THAN THOSE INDICATED. NONE
OF THE COMPANY NOR ITS SHAREHOLDERS, DIRECTORS, OFFICERS, EMPLOYEES, ADVISORS
OR AFFILIATES, OR ANY REPRESENTATIVES OR AFFILIATES OF THE FOREGOING, ASSUMES
RESPONSIBILITY FOR THE ACCURACY OF THE PROJECTIONS PRESENTED HEREIN.
The information contained in this communication or document, including but not
limited to forward-looking statements, applies only as of the date hereof and
is not intended to give any assurances as to future results. The Company
expressly disclaims any obligation or undertaking to disseminate any updates
or revisions to such information, including any financial data or
forward-looking statements, and will not publicly release any revisions it may
make to the Information that may result from any change in the Company's
expectations, any change in events, conditions or circumstances on which these
forward-looking statements are based, or other events or circumstances arising
after the date hereof.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOGSSLSAEEISEEU